Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 2953.0
(-0.07%)
JPY 2953.0
(-0.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 46.26 Billion JPY | -0.73% |
| 2022 | 46.6 Billion JPY | 3.2% |
| 2021 | 45.16 Billion JPY | 5.55% |
| 2020 | 42.78 Billion JPY | -0.75% |
| 2019 | 43.11 Billion JPY | -1.08% |
| 2018 | 43.58 Billion JPY | 4.01% |
| 2017 | 41.9 Billion JPY | -6.75% |
| 2016 | 44.93 Billion JPY | 4.88% |
| 2015 | 42.84 Billion JPY | 2.85% |
| 2014 | 41.65 Billion JPY | -3.09% |
| 2013 | 42.98 Billion JPY | 1.35% |
| 2012 | 42.41 Billion JPY | 2.38% |
| 2011 | 41.42 Billion JPY | 10.64% |
| 2010 | 37.44 Billion JPY | 5.47% |
| 2009 | 35.5 Billion JPY | 5.36% |
| 2008 | 33.69 Billion JPY | -2.13% |
| 2007 | 34.42 Billion JPY | -0.46% |
| 2006 | 34.58 Billion JPY | -1.3% |
| 2005 | 35.04 Billion JPY | -2.51% |
| 2004 | 35.94 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.79 Billion JPY | -7.85% |
| 2024 Q2 | 10.72 Billion JPY | -0.65% |
| 2023 FY | 46.26 Billion JPY | -0.73% |
| 2023 Q4 | 11.71 Billion JPY | -9.79% |
| 2023 Q3 | 12.98 Billion JPY | 19.44% |
| 2023 Q1 | 10.68 Billion JPY | -16.43% |
| 2023 Q2 | 10.87 Billion JPY | 1.73% |
| 2022 Q1 | 10.99 Billion JPY | -3.39% |
| 2022 Q4 | 12.79 Billion JPY | 19.91% |
| 2022 Q3 | 10.66 Billion JPY | -12.26% |
| 2022 Q2 | 12.15 Billion JPY | 10.6% |
| 2022 FY | 46.6 Billion JPY | 3.2% |
| 2021 Q4 | 11.37 Billion JPY | 3.57% |
| 2021 Q1 | 11.77 Billion JPY | 6.7% |
| 2021 FY | 45.16 Billion JPY | 5.55% |
| 2021 Q2 | 11.02 Billion JPY | -6.35% |
| 2021 Q3 | 10.98 Billion JPY | -0.35% |
| 2020 Q2 | 10.09 Billion JPY | 3.0% |
| 2020 FY | 42.78 Billion JPY | -0.75% |
| 2020 Q1 | 9.8 Billion JPY | -7.91% |
| 2020 Q4 | 11.03 Billion JPY | -6.92% |
| 2020 Q3 | 11.85 Billion JPY | 17.38% |
| 2019 Q2 | 10.77 Billion JPY | 12.09% |
| 2019 Q1 | 9.61 Billion JPY | -19.23% |
| 2019 FY | 43.11 Billion JPY | -1.08% |
| 2019 Q4 | 10.64 Billion JPY | -11.84% |
| 2019 Q3 | 12.07 Billion JPY | 12.06% |
| 2018 FY | 43.58 Billion JPY | 4.01% |
| 2018 Q2 | 11.15 Billion JPY | 17.07% |
| 2018 Q3 | 10.99 Billion JPY | -1.46% |
| 2018 Q4 | 11.9 Billion JPY | 8.27% |
| 2018 Q1 | 9.53 Billion JPY | -12.03% |
| 2017 Q4 | 10.83 Billion JPY | -2.95% |
| 2017 Q3 | 11.16 Billion JPY | 9.05% |
| 2017 Q1 | 9.67 Billion JPY | -27.93% |
| 2017 FY | 41.9 Billion JPY | -6.75% |
| 2017 Q2 | 10.23 Billion JPY | 5.82% |
| 2016 Q2 | 10.01 Billion JPY | -8.04% |
| 2016 Q4 | 13.42 Billion JPY | 26.58% |
| 2016 Q3 | 10.6 Billion JPY | 5.84% |
| 2016 FY | 44.93 Billion JPY | 4.88% |
| 2016 Q1 | 10.89 Billion JPY | -6.91% |
| 2015 FY | 42.84 Billion JPY | 2.85% |
| 2015 Q4 | 11.7 Billion JPY | 6.18% |
| 2015 Q3 | 11.02 Billion JPY | 3.47% |
| 2015 Q2 | 10.65 Billion JPY | 12.51% |
| 2015 Q1 | 9.46 Billion JPY | -0.92% |
| 2014 Q2 | 11.76 Billion JPY | 15.14% |
| 2014 Q3 | 10.11 Billion JPY | -13.99% |
| 2014 Q4 | 9.55 Billion JPY | -5.56% |
| 2014 FY | 41.65 Billion JPY | -3.09% |
| 2014 Q1 | 10.21 Billion JPY | -10.53% |
| 2013 Q1 | 10.1 Billion JPY | -3.35% |
| 2013 Q3 | 10.76 Billion JPY | 0.67% |
| 2013 Q4 | 11.42 Billion JPY | 6.06% |
| 2013 FY | 42.98 Billion JPY | 1.35% |
| 2013 Q2 | 10.69 Billion JPY | 5.84% |
| 2012 FY | 42.41 Billion JPY | 2.38% |
| 2012 Q3 | 12.19 Billion JPY | 21.16% |
| 2012 Q4 | 10.45 Billion JPY | -14.29% |
| 2012 Q1 | 9.69 Billion JPY | -4.03% |
| 2012 Q2 | 10.06 Billion JPY | 3.87% |
| 2011 Q1 | 10.88 Billion JPY | -2.59% |
| 2011 Q2 | 9.59 Billion JPY | -11.77% |
| 2011 Q4 | 10.1 Billion JPY | -6.89% |
| 2011 FY | 41.42 Billion JPY | 10.64% |
| 2011 Q3 | 10.84 Billion JPY | 13.0% |
| 2010 Q2 | 8.82 Billion JPY | 2.15% |
| 2010 Q1 | 8.64 Billion JPY | -5.07% |
| 2010 Q3 | 8.8 Billion JPY | -0.2% |
| 2010 Q4 | 11.16 Billion JPY | 26.81% |
| 2010 FY | 37.44 Billion JPY | 5.47% |
| 2009 Q2 | 8.32 Billion JPY | -1.12% |
| 2009 Q4 | 9.1 Billion JPY | -5.76% |
| 2009 Q3 | 9.65 Billion JPY | 16.01% |
| 2009 Q1 | 8.41 Billion JPY | -5.88% |
| 2009 FY | 35.5 Billion JPY | 5.36% |
| 2008 Q4 | 8.94 Billion JPY | 8.44% |
| 2008 Q2 | 8.4 Billion JPY | 0.0% |
| 2008 FY | 33.69 Billion JPY | -2.13% |
| 2008 Q3 | 8.24 Billion JPY | -1.86% |
| 2007 FY | 34.42 Billion JPY | -0.46% |
| 2006 FY | 34.58 Billion JPY | -1.3% |
| 2005 FY | 35.04 Billion JPY | -2.51% |
| 2004 FY | 35.94 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | -6.022% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 98.233% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 91.466% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 76.589% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -1138.291% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 29.504% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | -59.398% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 91.32% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -775.937% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 29.69% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -300.476% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -462.038% |
| Tsumura & Co. | 48.8 Billion JPY | 5.191% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | -38.84% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -136.817% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 27.408% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -265.545% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | -14.339% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | -1.921% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -1012.99% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -678.251% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -785.886% |
| MedRx Co., Ltd | 959 Million JPY | -4724.505% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -1509.999% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -3034.621% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -1851.646% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -91.463% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | -30.576% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -6193.28% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 53.648% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -1949.673% |